Takeda Announces New Diabetes Drug, Amid Actos Controversy

California Actos Bladder Cancer Attorney

A number of Actos cases were consolidated for pretrial proceedings.

Takeda Pharmaceuticals, the company behind the troubled diabetes drug Actos, has just received FDA approval for a new diabetes medication that uses the active ingredient alogliptin. Actos has been the subject of tremendous controversy as a result of numerous studies and thousands of lawsuits alleging severe side effects like heart failure and bladder cancer.

The drug is called Nesina, and is a DPP-4 inhibitor. So far, the most common side effects associated with Nesina are stuffy nose, runny nose, headache, and upper respiratory tract infection, but more research is still needed. There are already drugs with this active ingredient on the market, so Takeda will face some stiff competition as it attempts to restore its reputation and recover the lost revenue from Actos sales.

Approximately 24 million people live with type 2 diabetes, and the condition accounts for more than 90 percent of diabetes cases in the United States. Clearly we need an effective drug to manage the condition, but time will only tell if Nesina proves to be a positive alternative to Actos. While the new drug has fared very positively in its initial clinical trials, we have seen time and time again that the real side effects often don’t present themselves until the drug is introduced into the general population, and millions of people being relying on the drug to regulate their conditions.

The drug defect attorneys at Nadrich and Cohen LLP have been observing Takeda Pharmaceuticals and the impacts of Actos drug use for years. We will continue to monitor any developments as Nesina enters the market. We sincerely hope that Nesina proves to be a safe and effective alternative to Actos, but only time will tell.

If you or someone you love has experienced severe or devastating side effects resulting from Actos use, you may be entitled to compensation. Call an experienced California Actos attorney today at 1-800-718-4658 to receive a free and confidential consultation. We fight aggressively on behalf of our clients, and we will come to you if necessary. With more than a quarter century of experience, we have the expertise the skill to get the job done right. Additionally, we have recovered more than a billion dollars for our personal injury clients, and we don’t charge you any money if we don’t win your case. Call us today.

The Nadrich & Cohen personal injury blogs are sponsored by Nadrich & Cohen, LLC. This blog features news stories, personal cases and analysis of current events, all of which are intended for illustrative purposes only. Each case is different, and legal authority is constantly changing and evolving. Therefore, nothing on this site should be viewed as a guarantee or prediction of a similar future outcome. The information on this site should not be treated as authoritative, and readers should always consult with legal counsel before making any important legal decisions. Lastly, Nadrich & Cohen, LLC is not responsible for any comments contributed by visitors to this website.


  1. New Actos Alternative Wins FDA Approval; Personal Injury Lawyer Jeff Nadrich … | Atlanta Injury Attorney - 08. Feb, 2013

    […] and researching the effects of Actos for years, and just this week, Nadrich released a statement on his blog regarding the future of Nesina and diabetes […]

Leave a Reply

Name (required)

Email (will not be published) (required)